Articles dans des revues avec comité de lecture (144)
  1. 105. Varin, A., Manna, S. K., Quivy, V., Decrion, A.-Z., Van Lint, C., Herbein, G., & Aggarwal, B. B. (2003). Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. The Journal of biological chemistry, 278(4), 2219-2227. doi:10.1074/jbc.M209622200
  2. 106. Maurer, P., T'Sas, F., Coutte, L., Callens, N., Brenner, C., Van Lint, C., De Launoit, Y., & Baert, J.-L. (2003). FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain. Oncogene, 22(21), 3319-3329. doi:10.1038/sj.onc.1206572
  3. 107. Harrod, R., Nacsa, J., Van Lint, C., Hansen, J., Karpova, T., McNally, J., & Franchini, G. (2003). Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription. The Journal of biological chemistry, 278(14), 12310-12318. doi:10.1074/jbc.M211167200
  4. 108. Dekoninck, A., Calomme, C., Nizet, S., De Launoit, Y., Burny, A., Ghysdael, J., & Van Lint, C. (2003). Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat. Oncogene, 22(19), 2882-2896. doi:10.1038/sj.onc.1206392
  5. 109. Viatour, P., Legrand-Poels, S., Van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., Bours, V., & Chariot, A. (2003). Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. The Journal of biological chemistry, 278(47), 46541-46548. doi:10.1074/jbc.M306381200
  6. 110. Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Schoonbroodt, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., De Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (2003). Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Molecular and cellular biology, 23(17), 6200-6209. doi:10.1128/MCB.23.17.6200-6209.2003
  7. 111. Callens, N., Baert, J.-L., Sunesen, M., Van Lint, C., & De Launoit, Y. (2003). Transcriptional regulation of the murine brca2 gene by CREB/ATF transcription factors. Biochemical and biophysical research communications, 312(3), 702-707. doi:10.1016/j.bbrc.2003.10.176
  8. 112. Pouillon, V., Hascakova-Bartova, R., Pajak, B., Adam, E., Bex, F., Dewaste, V., Van Lint, C., Leo, O., Erneux, C., & Schurmans, S. (2003). Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. Nature immunology, 4(11), 1136-1143. doi:10.1038/ni980
  9. 113. Goriely, S., Demonte, D., Nizet, S., De Wit, D., Willems, F., Goldman, M., & Van Lint, C. (2003). Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. Blood, 101(12), 4894-4902. doi:10.1182/blood-2002-09-2851
  10. 114. Szynal, M., Cleuter, Y., Beskorwayne, T., Bagnis, C., Van Lint, C., Kerkhofs, P., Burny, A., Martiat, P., Griebel, P., & Van Den Broeke, A. (2003). Disruption of B-cell homeostatic control mediated by the BLV-Tax oncoprotein: association with the upregulation of Bcl-2 and signaling through NF-kappaB. Oncogene, 22(29), 4531-4542. doi:10.1038/sj.onc.1206546
  11. 115. Callens, N., Dumont, M., Begue, A., Van Lint, C., Baert, J.-L., Simard, J., & De Launoit, Y. (2002). Genomic organization and expression of the mouse Brca2 gene. Mammalian genome, 13(7), 352-358. doi:10.1007/s00335-002-2300-2
  12. 116. Callens, N., Dumont, M., Begue, A., Van Lint, C., Baert, J.-L., Simard, J., & De Launoit, Y. (2002). Genomic organization and expression of the mouse Brca2 gene. Mammalian genome, 13(7), 352-358.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>